APO Research, Inc.
Talk to an analyst

APO RESEARCH · REPORT

Prilide Antihypertensive Drugs

Compare research editions
View pricing & licenses

Selected research

Market Analysis & Forecast

Global Prilide Antihypertensive Drugs Market Analysis and Forecast 2026-2032

Report ID 174028440222 December 2025209 pages

Choose your research edition.

Industry ResearchPrilide Antihypertensive Drugs Industry Research Report 2026139 pages · $2,950 USDIndustry Growth & TrendsGlobal Prilide Antihypertensive Drugs Industry Growth and Trends Forecast to 2032111 pages · $3,450 USDMarket StructureGlobal Prilide Antihypertensive Drugs Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032198 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal Prilide Antihypertensive Drugs Market Outlook and Growth Opportunities 2026207 pages · $4,250 USDMarket Analysis & ForecastGlobal Prilide Antihypertensive Drugs Market Analysis and Forecast 2026-2032209 pages · $4,950 USD

Market perspective

The global Prilide Antihypertensive Drugs market is projected to grow from US$ million in 2026 to US$ million by 2032, at a Compound Annual Growth Rate (CAGR) of % during the forecast period.

The US & Canada market for Prilide Antihypertensive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Europe market for Prilide Antihypertensive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

Read the full market overview

Asia-Pacific market for Prilide Antihypertensive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The China market for Prilide Antihypertensive Drugs is estimated to increase from $ million in 2026 to reach $ million by 2032, at a CAGR of % during the forecast period of 2026 through 2032.

The major global manufacturers of Prilide Antihypertensive Drugs include Zhongfu Pharmaceutical, Huahai Pharmaceutical, Changjiang Pharmaceutical, Abbott, Sanofi, Humanwell Pharmaceutical, Poly Pharm, Novartis and Merck, etc. In 2025, the world's top three vendors accounted for approximately % of the revenue.

This report presents an overview of global market for Prilide Antihypertensive Drugs, sales, revenue and price. Analyses of the global market trends, with historic market revenue or sales data for 2021 - 2025, estimates for 2026, and projections of CAGR through 2032.

This report researches the key producers of Prilide Antihypertensive Drugs, also provides the sales of main regions and countries. Of the upcoming market potential for Prilide Antihypertensive Drugs, and key regions or countries of focus to forecast this market into various segments and sub-segments. Country specific data and market value analysis for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, Middle East, Africa, and Other Countries.

This report focuses on the Prilide Antihypertensive Drugs sales, revenue, market share and industry ranking of main manufacturers, data from 2021 to 2026. Identification of the major stakeholders in the global Prilide Antihypertensive Drugs market, and analysis of their competitive landscape and market positioning based on recent developments and segmental revenues. This report will help stakeholders to understand the competitive landscape and gain more insights and position their businesses and market strategies in a better way.

This report analyzes the segments data by Type and by Application, sales, revenue, and price, from 2021 to 2032. Evaluation and forecast the market size for Prilide Antihypertensive Drugs sales, projected growth trends, production technology, application and end-user industry.

Prilide Antihypertensive Drugs Segment by Company

Zhongfu Pharmaceutical

Huahai Pharmaceutical

Changjiang Pharmaceutical

Abbott

Sanofi

Humanwell Pharmaceutical

Poly Pharm

Novartis

Merck

Lukang Group

Likang Pharmaceutical

Pfizer

Hengwei Pharmaceutical

Hengcheng Pharmaceutical

Changzhou Pharmaceutical

Baili Pharmaceutical

Baiyunshan Pharmaceutical

Prilide Antihypertensive Drugs Segment by Type

Enalapril

Lisinopril

Captopril

Fosinopril

Others

Prilide Antihypertensive Drugs Segment by Application

Hospital

Clinic

Prilide Antihypertensive Drugs Segment by Region

North America

United States

Canada

Mexico

Europe

Germany

France

U.K.

Italy

Russia

Spain

Netherlands

Switzerland

Sweden

Poland

Asia-Pacific

China

Japan

South Korea

India

Australia

Taiwan

Southeast Asia

South America

Brazil

Argentina

Chile

Middle East & Africa

Egypt

South Africa

Israel

Türkiye

GCC Countries

Study Objectives

1. To analyze and research the global status and future forecast, involving growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, sales, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global Prilide Antihypertensive Drugs market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of Prilide Antihypertensive Drugs and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in sales and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of Prilide Antihypertensive Drugs.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by type and by application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Sales (consumption), revenue of Prilide Antihypertensive Drugs in global, regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space of each country in the world.

Chapter 4: Detailed analysis of Prilide Antihypertensive Drugs manufacturers competitive landscape, price, sales, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 5: Provides the analysis of various market segments by type, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 6: Provides the analysis of various market segments by application, covering the sales, revenue, average price, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 7: Provides profiles of key manufacturers, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, Prilide Antihypertensive Drugs sales, revenue, price, gross margin, and recent development, etc.

Chapter 8: North America by type, by application and by country, sales, and revenue for each segment.

Chapter 9: Europe by type, by application and by country, sales, and revenue for each segment.

Chapter 10: China type, by application, sales, and revenue for each segment.

Chapter 11: Asia (excluding China) type, by application and by region, sales, and revenue for each segment.

Chapter 12: South America, Middle East and Africa by type, by application and by country, sales, and revenue for each segment.

Chapter 13: Analysis of industrial chain, sales channel, key raw materials, distributors and customers.

Chapter 14: The main concluding insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global Prilide Antihypertensive Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Table 2. Enalapril Major Manufacturers Table 3. Lisinopril Major Manufacturers Table 4. Captopril Major Manufacturers Table 5. Fosinopril Major Manufacturers Table 6. Others Major Manufacturers Table 7. Global Prilide Antihypertensive Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Table 8. Hospital Major Manufacturers Table 9. Clinic Major Manufacturers Table 10. Prilide Antihypertensive Drugs Industry Trends Table 11. Prilide Antihypertensive Drugs Industry Drivers Table 12. Prilide Antihypertensive Drugs Industry Opportunities and Challenges Table 13. Prilide Antihypertensive Drugs Industry Restraints Table 14. Global Prilide Antihypertensive Drugs Revenue Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Table 15. Global Prilide Antihypertensive Drugs Revenue by Region (2021-2026) & (US$ Million) Table 16. Global Prilide Antihypertensive Drugs Revenue by Region (2027-2032) & (US$ Million) Table 17. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2021-2026) Table 18. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2027-2032) Table 19. Global Prilide Antihypertensive Drugs Sales Grow Rate (CAGR) by Region: 2021 VS 2025 VS 2032 (k units) Table 20. Global Prilide Antihypertensive Drugs Sales by Region (2021-2026) & (k units) Table 21. Global Prilide Antihypertensive Drugs Sales by Region (2027-2032) & (k units) Table 22. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2021-2026) Table 23. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2027-2032) Table 24. Global Prilide Antihypertensive Drugs Revenue by Manufacturers (US$ Million) & (2021-2026) Table 25. Global Prilide Antihypertensive Drugs Revenue Market Share by Manufacturers (2021-2026) Table 26. Global Prilide Antihypertensive Drugs Sales by Manufacturers (US$ Million) & (2021-2026) Table 27. Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2021-2026) Table 28. Global Prilide Antihypertensive Drugs Sales Price (US$/unit) of Manufacturers (2021-2026) Table 29. Global Prilide Antihypertensive Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026 Table 30. Global Prilide Antihypertensive Drugs Key Manufacturers Manufacturing Sites & Headquarters Table 31. Global Prilide Antihypertensive Drugs Manufacturers, Product Type & Application Table 32. Global Prilide Antihypertensive Drugs Manufacturers' Establishment Date Table 33. Global Manufacturers Market Concentration Ratio (CR5 and HHI) Table 34. Global Prilide Antihypertensive Drugs by Manufacturers Type (Tier 1, Tier 2, and Tier 3) & (Based on the Revenue of 2025) Table 35. Global Prilide Antihypertensive Drugs Revenue by Type 2021 VS 2025 VS 2032 (US$ Million) Table 36. Global Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 37. Global Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 38. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2026) Table 39. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2027-2032) Table 40. Global Prilide Antihypertensive Drugs Sales by Type 2021 VS 2025 VS 2032 (k units) Table 41. Global Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 42. Global Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 43. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2026) Table 44. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2027-2032) Table 45. Global Prilide Antihypertensive Drugs Price by Type (2021-2026) & (US$/unit) Table 46. Global Prilide Antihypertensive Drugs Price by Type (2027-2032) & (US$/unit) Table 47. Global Prilide Antihypertensive Drugs Revenue by Application 2021 VS 2025 VS 2032 (US$ Million) Table 48. Global Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 49. Global Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 50. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2026) Table 51. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2027-2032) Table 52. Global Prilide Antihypertensive Drugs Sales by Application 2021 VS 2025 VS 2032 (k units) Table 53. Global Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 54. Global Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 55. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2026) Table 56. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2027-2032) Table 57. Global Prilide Antihypertensive Drugs Price by Application (2021-2026) & (US$/unit) Table 58. Global Prilide Antihypertensive Drugs Price by Application (2027-2032) & (US$/unit) Table 59. Zhongfu Pharmaceutical Company Information Table 60. Zhongfu Pharmaceutical Business Overview Table 61. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 62. Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 63. Zhongfu Pharmaceutical Recent Development Table 64. Huahai Pharmaceutical Company Information Table 65. Huahai Pharmaceutical Business Overview Table 66. Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 67. Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 68. Huahai Pharmaceutical Recent Development Table 69. Changjiang Pharmaceutical Company Information Table 70. Changjiang Pharmaceutical Business Overview Table 71. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 72. Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 73. Changjiang Pharmaceutical Recent Development Table 74. Abbott Company Information Table 75. Abbott Business Overview Table 76. Abbott Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 77. Abbott Prilide Antihypertensive Drugs Product Portfolio Table 78. Abbott Recent Development Table 79. Sanofi Company Information Table 80. Sanofi Business Overview Table 81. Sanofi Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 82. Sanofi Prilide Antihypertensive Drugs Product Portfolio Table 83. Sanofi Recent Development Table 84. Humanwell Pharmaceutical Company Information Table 85. Humanwell Pharmaceutical Business Overview Table 86. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 87. Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 88. Humanwell Pharmaceutical Recent Development Table 89. Poly Pharm Company Information Table 90. Poly Pharm Business Overview Table 91. Poly Pharm Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 92. Poly Pharm Prilide Antihypertensive Drugs Product Portfolio Table 93. Poly Pharm Recent Development Table 94. Novartis Company Information Table 95. Novartis Business Overview Table 96. Novartis Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 97. Novartis Prilide Antihypertensive Drugs Product Portfolio Table 98. Novartis Recent Development Table 99. Merck Company Information Table 100. Merck Business Overview Table 101. Merck Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 102. Merck Prilide Antihypertensive Drugs Product Portfolio Table 103. Merck Recent Development Table 104. Lukang Group Company Information Table 105. Lukang Group Business Overview Table 106. Lukang Group Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 107. Lukang Group Prilide Antihypertensive Drugs Product Portfolio Table 108. Lukang Group Recent Development Table 109. Likang Pharmaceutical Company Information Table 110. Likang Pharmaceutical Business Overview Table 111. Likang Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 112. Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 113. Likang Pharmaceutical Recent Development Table 114. Pfizer Company Information Table 115. Pfizer Business Overview Table 116. Pfizer Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 117. Pfizer Prilide Antihypertensive Drugs Product Portfolio Table 118. Pfizer Recent Development Table 119. Hengwei Pharmaceutical Company Information Table 120. Hengwei Pharmaceutical Business Overview Table 121. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 122. Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 123. Hengwei Pharmaceutical Recent Development Table 124. Hengcheng Pharmaceutical Company Information Table 125. Hengcheng Pharmaceutical Business Overview Table 126. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 127. Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 128. Hengcheng Pharmaceutical Recent Development Table 129. Changzhou Pharmaceutical Company Information Table 130. Changzhou Pharmaceutical Business Overview Table 131. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 132. Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 133. Changzhou Pharmaceutical Recent Development Table 134. Baili Pharmaceutical Company Information Table 135. Baili Pharmaceutical Business Overview Table 136. Baili Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 137. Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 138. Baili Pharmaceutical Recent Development Table 139. Baiyunshan Pharmaceutical Company Information Table 140. Baiyunshan Pharmaceutical Business Overview Table 141. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales (k units), Revenue (US$ Million), Price (US$/unit) and Gross Margin (2021-2026) Table 142. Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio Table 143. Baiyunshan Pharmaceutical Recent Development Table 144. North America Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 145. North America Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 146. North America Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 147. North America Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 148. North America Prilide Antihypertensive Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 149. North America Prilide Antihypertensive Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 150. North America Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 151. North America Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 152. North America Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 153. North America Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 154. North America Prilide Antihypertensive Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 155. North America Prilide Antihypertensive Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 156. North America Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 157. North America Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 158. North America Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 159. North America Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 160. North America Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 161. North America Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 162. North America Prilide Antihypertensive Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 163. North America Prilide Antihypertensive Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 164. United States Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 165. Canada Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 166. Mexico Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 167. Europe Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 168. Europe Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 169. Europe Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 170. Europe Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 171. Europe Prilide Antihypertensive Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 172. Europe Prilide Antihypertensive Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 173. Europe Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 174. Europe Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 175. Europe Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 176. Europe Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 177. Europe Prilide Antihypertensive Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 178. Europe Prilide Antihypertensive Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 179. Europe Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 180. Europe Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 181. Europe Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 182. Europe Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 183. Europe Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 184. Europe Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 185. Europe Prilide Antihypertensive Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 186. Europe Prilide Antihypertensive Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 187. Germany Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 188. France Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 189. U.K. Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 190. Italy Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 191. Russia Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 192. Spain Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 193. Netherlands Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 194. Switzerland Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 195. Sweden Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 196. Poland Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 197. China Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 198. China Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 199. China Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 200. China Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 201. China Prilide Antihypertensive Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 202. China Prilide Antihypertensive Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 203. China Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 204. China Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 205. China Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 206. China Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 207. China Prilide Antihypertensive Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 208. China Prilide Antihypertensive Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 209. Asia Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 210. Asia Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 211. Asia Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 212. Asia Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 213. Asia Prilide Antihypertensive Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 214. Asia Prilide Antihypertensive Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 215. Asia Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 216. Asia Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 217. Asia Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 218. Asia Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 219. Asia Prilide Antihypertensive Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 220. Asia Prilide Antihypertensive Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 221. Asia Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 222. Asia Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 223. Asia Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 224. Asia Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 225. Asia Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 226. Asia Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 227. Asia Prilide Antihypertensive Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 228. Asia Prilide Antihypertensive Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 229. Japan Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 230. South Korea Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 231. India Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 232. Australia Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 233. Taiwan Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 234. Southeast Asia Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 235. SAMEA Prilide Antihypertensive Drugs Revenue by Type (2021-2026) & (US$ Million) Table 236. SAMEA Prilide Antihypertensive Drugs Revenue by Type (2027-2032) & (US$ Million) Table 237. SAMEA Prilide Antihypertensive Drugs Sales by Type (2021-2026) & (k units) Table 238. SAMEA Prilide Antihypertensive Drugs Sales by Type (2027-2032) & (k units) Table 239. SAMEA Prilide Antihypertensive Drugs Sales Price by Type (2021-2026) & (US$/unit) Table 240. SAMEA Prilide Antihypertensive Drugs Sales Price by Type (2027-2032) & (US$/unit) Table 241. SAMEA Prilide Antihypertensive Drugs Revenue by Application (2021-2026) & (US$ Million) Table 242. SAMEA Prilide Antihypertensive Drugs Revenue by Application (2027-2032) & (US$ Million) Table 243. SAMEA Prilide Antihypertensive Drugs Sales by Application (2021-2026) & (k units) Table 244. SAMEA Prilide Antihypertensive Drugs Sales by Application (2027-2032) & (k units) Table 245. SAMEA Prilide Antihypertensive Drugs Sales Price by Application (2021-2026) & (US$/unit) Table 246. SAMEA Prilide Antihypertensive Drugs Sales Price by Application (2027-2032) & (US$/unit) Table 247. SAMEA Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 248. SAMEA Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021-2026) & (US$ Million) Table 249. SAMEA Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2027-2032) & (US$ Million) Table 250. SAMEA Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032) & (k units) Table 251. SAMEA Prilide Antihypertensive Drugs Sales by Country (2021-2026) & (k units) Table 252. SAMEA Prilide Antihypertensive Drugs Sales by Country (2027-2032) & (k units) Table 253. SAMEA Prilide Antihypertensive Drugs Sales Price by Country (2021-2026) & (US$/unit) Table 254. SAMEA Prilide Antihypertensive Drugs Sales Price by Country (2027-2032) & (US$/unit) Table 255. Brazil Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 256. Argentina Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 257. Chile Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 258. Colombia Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 259. Peru Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 260. Saudi Arabia Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 261. Israel Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 262. UAE Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 263. Turkey Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 264. Iran Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 265. Egypt Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Table 266. Key Raw Materials Table 267. Raw Materials Key Suppliers Table 268. Prilide Antihypertensive Drugs Distributors List Table 269. Prilide Antihypertensive Drugs Customers List Table 270. Research Programs/Design for This Report Table 271. Authors List of This Report Table 272. Secondary Sources Table 273. Primary Sources List of Figures Figure 1. Prilide Antihypertensive Drugs Image Figure 2. Global Prilide Antihypertensive Drugs Market Size Growth Rate by Type (US$ Million), 2021 VS 2025 VS 2032 Figure 3. Global Prilide Antihypertensive Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 4. Enalapril Image Figure 5. Lisinopril Image Figure 6. Captopril Image Figure 7. Fosinopril Image Figure 8. Others Image Figure 9. Global Prilide Antihypertensive Drugs Market Size Growth Rate by Application (US$ Million), 2021 VS 2025 VS 2032 Figure 10. Global Prilide Antihypertensive Drugs Market Size Share 2021 VS 2025 VS 2032 Figure 11. Hospital Image Figure 12. Clinic Image Figure 13. Global Prilide Antihypertensive Drugs Revenue (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global Prilide Antihypertensive Drugs Revenue (2021-2032) & (US$ Million) Figure 15. Global Prilide Antihypertensive Drugs Revenue (CAGR) by Region: 2021 VS 2025 VS 2032 (US$ Million) Figure 16. Global Prilide Antihypertensive Drugs Revenue Market Share by Region: 2025 Versus 2032 Figure 17. Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2021-2032) Figure 18. Global Prilide Antihypertensive Drugs Sales (2021-2032) & (k units) Figure 19. Global Prilide Antihypertensive Drugs Sales by Region: 2021 VS 2025 VS 2032 (k units) Figure 20. Global Prilide Antihypertensive Drugs Sales Market Share by Region (2021-2032) Figure 21. US & Canada & Mexico Prilide Antihypertensive Drugs Sales YoY (2021-2032) & (k units) Figure 22. Europe Prilide Antihypertensive Drugs Sales YoY (2021-2032) & (k units) Figure 23. China Prilide Antihypertensive Drugs Sales YoY (2021-2032) & (k units) Figure 24. Asia (Excluding China) Prilide Antihypertensive Drugs Sales YoY (2021-2032) & (k units) Figure 25. South America, Middle East and Africa Prilide Antihypertensive Drugs Sales YoY (2021-2032) & (k units) Figure 26. Global Prilide Antihypertensive Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025 Figure 27. Global Prilide Antihypertensive Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025 Figure 28. Manufacturers Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 29. Global Prilide Antihypertensive Drugs Revenue by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 30. Global Prilide Antihypertensive Drugs Revenue Market Share by Type 2021 VS 2025 VS 2032 Figure 31. Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2032) Figure 32. Global Prilide Antihypertensive Drugs Sales by Type (2021 VS 2025 VS 2032) & (k units) Figure 33. Global Prilide Antihypertensive Drugs Sales Market Share by Type 2021 VS 2025 VS 2032 Figure 34. Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2032) Figure 35. Global Prilide Antihypertensive Drugs Revenue by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 36. Global Prilide Antihypertensive Drugs Revenue Market Share by Application 2021 VS 2025 VS 2032 Figure 37. Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2032) Figure 38. Global Prilide Antihypertensive Drugs Sales by Application (2021 VS 2025 VS 2032) & (k units) Figure 39. Global Prilide Antihypertensive Drugs Sales Market Share by Application 2021 VS 2025 VS 2032 Figure 40. Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2032) Figure 41. North America Prilide Antihypertensive Drugs Revenue Share by Type (2021-2032) Figure 42. North America Prilide Antihypertensive Drugs Sales Share by Type (2021-2032) Figure 43. North America Prilide Antihypertensive Drugs Revenue Share by Application (2021-2032) Figure 44. North America Prilide Antihypertensive Drugs Sales Share by Application (2021-2032) Figure 45. North America Prilide Antihypertensive Drugs Revenue Share by Country (2021-2032) Figure 46. North America Prilide Antihypertensive Drugs Sales Share by Country (2021-2032) Figure 47. Europe Prilide Antihypertensive Drugs Revenue Share by Type (2021-2032) Figure 48. Europe Prilide Antihypertensive Drugs Sales Share by Type (2021-2032) Figure 49. Europe Prilide Antihypertensive Drugs Revenue Share by Application (2021-2032) Figure 50. Europe Prilide Antihypertensive Drugs Sales Share by Application (2021-2032) Figure 51. Europe Prilide Antihypertensive Drugs Revenue Share by Country (2021-2032) Figure 52. Europe Prilide Antihypertensive Drugs Sales Share by Country (2021-2032) Figure 53. China Prilide Antihypertensive Drugs Revenue Share by Type (2021-2032) Figure 54. China Prilide Antihypertensive Drugs Sales Share by Type (2021-2032) Figure 55. China Prilide Antihypertensive Drugs Revenue Share by Application (2021-2032) Figure 56. China Prilide Antihypertensive Drugs Sales Share by Application (2021-2032) Figure 57. Asia Prilide Antihypertensive Drugs Revenue Share by Type (2021-2032) Figure 58. Asia Prilide Antihypertensive Drugs Sales Share by Type (2021-2032) Figure 59. Asia Prilide Antihypertensive Drugs Revenue Share by Application (2021-2032) Figure 60. Asia Prilide Antihypertensive Drugs Sales Share by Application (2021-2032) Figure 61. Asia Prilide Antihypertensive Drugs Revenue Share by Country (2021-2032) Figure 62. Asia Prilide Antihypertensive Drugs Sales Share by Country (2021-2032) Figure 63. SAMEA Prilide Antihypertensive Drugs Revenue Share by Type (2021-2032) Figure 64. SAMEA Prilide Antihypertensive Drugs Sales Share by Type (2021-2032) Figure 65. SAMEA Prilide Antihypertensive Drugs Revenue Share by Application (2021-2032) Figure 66. SAMEA Prilide Antihypertensive Drugs Sales Share by Application (2021-2032) Figure 67. SAMEA Prilide Antihypertensive Drugs Revenue Share by Country (2021-2032) Figure 68. SAMEA Prilide Antihypertensive Drugs Sales Share by Country (2021-2032) Figure 69. Prilide Antihypertensive Drugs Value Chain Figure 70. Manufacturing Cost Structure Figure 71. Prilide Antihypertensive Drugs Production Mode & Process Figure 72. Direct Comparison with Distribution Share Figure 73. Distributors Profiles Figure 74. Years Considered Figure 75. Research Process Figure 76. Key Executives Interviewed

Scope & coverage.

Types
  • Enalapril
  • Lisinopril
  • Captopril
  • Fosinopril
  • Others
Applications
  • Hospital
  • Clinic
Companies covered
  • Zhongfu Pharmaceutical
  • Huahai Pharmaceutical
  • Changjiang Pharmaceutical
  • Abbott
  • Sanofi
  • Humanwell Pharmaceutical
  • Poly Pharm
  • Novartis
  • Merck
  • Lukang Group
  • Likang Pharmaceutical
  • Pfizer
  • Hengwei Pharmaceutical
  • Hengcheng Pharmaceutical
  • Changzhou Pharmaceutical
  • Baili Pharmaceutical
  • Baiyunshan Pharmaceutical

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Prilide Antihypertensive Drugs Market by Type
  3. 1.2.1 Global Prilide Antihypertensive Drugs Market Size by Type, 2021 VS 2025 VS 2032
  4. 1.2.2 Enalapril
  5. 1.2.3 Lisinopril
  6. 1.2.4 Captopril
  7. 1.2.5 Fosinopril
  8. 1.2.6 Others
  9. 1.3 Prilide Antihypertensive Drugs Market by Application
  10. 1.3.1 Global Prilide Antihypertensive Drugs Market Size by Application, 2021 VS 2025 VS 2032
  11. 1.3.2 Hospital
  12. 1.3.3 Clinic
  13. 1.4 Assumptions and Limitations
  14. 1.5 Study Goals and Objectives
2 Prilide Antihypertensive Drugs Market Dynamics
  1. 2.1 Prilide Antihypertensive Drugs Industry Trends
  2. 2.2 Prilide Antihypertensive Drugs Industry Drivers
  3. 2.3 Prilide Antihypertensive Drugs Industry Opportunities and Challenges
  4. 2.4 Prilide Antihypertensive Drugs Industry Restraints
3 Global Market Growth Prospects
  1. 3.1 Global Prilide Antihypertensive Drugs Revenue Estimates and Forecasts (2021-2032)
  2. 3.2 Global Prilide Antihypertensive Drugs Revenue by Region
  3. 3.2.1 Global Prilide Antihypertensive Drugs Revenue by Region: 2021 VS 2025 VS 2032
  4. 3.2.2 Global Prilide Antihypertensive Drugs Revenue by Region (2021-2026)
  5. 3.2.3 Global Prilide Antihypertensive Drugs Revenue by Region (2027-2032)
  6. 3.2.4 Global Prilide Antihypertensive Drugs Revenue Market Share by Region (2021-2032)
  7. 3.3 Global Prilide Antihypertensive Drugs Sales Estimates and Forecasts 2021-2032
  8. 3.4 Global Prilide Antihypertensive Drugs Sales by Region
  9. 3.4.1 Global Prilide Antihypertensive Drugs Sales by Region: 2021 VS 2025 VS 2032
  10. 3.4.2 Global Prilide Antihypertensive Drugs Sales by Region (2021-2026)
  11. 3.4.3 Global Prilide Antihypertensive Drugs Sales by Region (2027-2032)
  12. 3.4.4 Global Prilide Antihypertensive Drugs Sales Market Share by Region (2021-2032)
  13. 3.5 US & Canada & Mexico
  14. 3.6 Europe
  15. 3.7 China
  16. 3.8 Asia (Excluding China)
  17. 3.9 South America, Middle East and Africa
4 Market Competitive Landscape by Manufacturers
  1. 4.1 Global Prilide Antihypertensive Drugs Revenue by Manufacturers
  2. 4.1.1 Global Prilide Antihypertensive Drugs Revenue by Manufacturers (2021-2026)
  3. 4.1.2 Global Prilide Antihypertensive Drugs Revenue Market Share by Manufacturers (2021-2026)
  4. 4.1.3 Global Prilide Antihypertensive Drugs Manufacturers Revenue Share Top 10 and Top 5 in 2025
  5. 4.2 Global Prilide Antihypertensive Drugs Sales by Manufacturers
  6. 4.2.1 Global Prilide Antihypertensive Drugs Sales by Manufacturers (2021-2026)
  7. 4.2.2 Global Prilide Antihypertensive Drugs Sales Market Share by Manufacturers (2021-2026)
  8. 4.2.3 Global Prilide Antihypertensive Drugs Manufacturers Sales Share Top 10 and Top 5 in 2025
  9. 4.3 Global Prilide Antihypertensive Drugs Sales Price by Manufacturers (2021-2026)
  10. 4.4 Global Prilide Antihypertensive Drugs Key Manufacturers Ranking, 2024 VS 2025 VS 2026
  11. 4.5 Global Prilide Antihypertensive Drugs Key Manufacturers Manufacturing Sites & Headquarters
  12. 4.6 Global Prilide Antihypertensive Drugs Manufacturers, Product Type & Application
  13. 4.7 Global Prilide Antihypertensive Drugs Manufacturers' Establishment Date
  14. 4.8 Market Competitive Analysis
  15. 4.8.1 Global Prilide Antihypertensive Drugs Market CR5 and HHI
  16. 4.8.2 2025 Prilide Antihypertensive Drugs Tier 1, Tier 2, and Tier 3
5 Prilide Antihypertensive Drugs Market by Type
  1. 5.1 Global Prilide Antihypertensive Drugs Revenue by Type
  2. 5.1.1 Global Prilide Antihypertensive Drugs Revenue by Type (2021 VS 2025 VS 2032)
  3. 5.1.2 Global Prilide Antihypertensive Drugs Revenue by Type (2021-2032) & (US$ Million)
  4. 5.1.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Type (2021-2032)
  5. 5.2 Global Prilide Antihypertensive Drugs Sales by Type
  6. 5.2.1 Global Prilide Antihypertensive Drugs Sales by Type (2021 VS 2025 VS 2032)
  7. 5.2.2 Global Prilide Antihypertensive Drugs Sales by Type (2021-2032) & (k units)
  8. 5.2.3 Global Prilide Antihypertensive Drugs Sales Market Share by Type (2021-2032)
  9. 5.3 Global Prilide Antihypertensive Drugs Price by Type
6 Prilide Antihypertensive Drugs Market by Application
  1. 6.1 Global Prilide Antihypertensive Drugs Revenue by Application
  2. 6.1.1 Global Prilide Antihypertensive Drugs Revenue by Application (2021 VS 2025 VS 2032)
  3. 6.1.2 Global Prilide Antihypertensive Drugs Revenue by Application (2021-2032) & (US$ Million)
  4. 6.1.3 Global Prilide Antihypertensive Drugs Revenue Market Share by Application (2021-2032)
  5. 6.2 Global Prilide Antihypertensive Drugs Sales by Application
  6. 6.2.1 Global Prilide Antihypertensive Drugs Sales by Application (2021 VS 2025 VS 2032)
  7. 6.2.2 Global Prilide Antihypertensive Drugs Sales by Application (2021-2032) & (k units)
  8. 6.2.3 Global Prilide Antihypertensive Drugs Sales Market Share by Application (2021-2032)
  9. 6.3 Global Prilide Antihypertensive Drugs Price by Application
7 Company Profiles
  1. 7.1 Zhongfu Pharmaceutical
  2. 7.1.1 Zhongfu Pharmaceutical Company Information
  3. 7.1.2 Zhongfu Pharmaceutical Business Overview
  4. 7.1.3 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  5. 7.1.4 Zhongfu Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  6. 7.1.5 Zhongfu Pharmaceutical Recent Developments
  7. 7.2 Huahai Pharmaceutical
  8. 7.2.1 Huahai Pharmaceutical Company Information
  9. 7.2.2 Huahai Pharmaceutical Business Overview
  10. 7.2.3 Huahai Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  11. 7.2.4 Huahai Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  12. 7.2.5 Huahai Pharmaceutical Recent Developments
  13. 7.3 Changjiang Pharmaceutical
  14. 7.3.1 Changjiang Pharmaceutical Company Information
  15. 7.3.2 Changjiang Pharmaceutical Business Overview
  16. 7.3.3 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  17. 7.3.4 Changjiang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  18. 7.3.5 Changjiang Pharmaceutical Recent Developments
  19. 7.4 Abbott
  20. 7.4.1 Abbott Company Information
  21. 7.4.2 Abbott Business Overview
  22. 7.4.3 Abbott Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  23. 7.4.4 Abbott Prilide Antihypertensive Drugs Product Portfolio
  24. 7.4.5 Abbott Recent Developments
  25. 7.5 Sanofi
  26. 7.5.1 Sanofi Company Information
  27. 7.5.2 Sanofi Business Overview
  28. 7.5.3 Sanofi Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  29. 7.5.4 Sanofi Prilide Antihypertensive Drugs Product Portfolio
  30. 7.5.5 Sanofi Recent Developments
  31. 7.6 Humanwell Pharmaceutical
  32. 7.6.1 Humanwell Pharmaceutical Company Information
  33. 7.6.2 Humanwell Pharmaceutical Business Overview
  34. 7.6.3 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  35. 7.6.4 Humanwell Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  36. 7.6.5 Humanwell Pharmaceutical Recent Developments
  37. 7.7 Poly Pharm
  38. 7.7.1 Poly Pharm Company Information
  39. 7.7.2 Poly Pharm Business Overview
  40. 7.7.3 Poly Pharm Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  41. 7.7.4 Poly Pharm Prilide Antihypertensive Drugs Product Portfolio
  42. 7.7.5 Poly Pharm Recent Developments
  43. 7.8 Novartis
  44. 7.8.1 Novartis Company Information
  45. 7.8.2 Novartis Business Overview
  46. 7.8.3 Novartis Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  47. 7.8.4 Novartis Prilide Antihypertensive Drugs Product Portfolio
  48. 7.8.5 Novartis Recent Developments
  49. 7.9 Merck
  50. 7.9.1 Merck Company Information
  51. 7.9.2 Merck Business Overview
  52. 7.9.3 Merck Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  53. 7.9.4 Merck Prilide Antihypertensive Drugs Product Portfolio
  54. 7.9.5 Merck Recent Developments
  55. 7.10 Lukang Group
  56. 7.10.1 Lukang Group Company Information
  57. 7.10.2 Lukang Group Business Overview
  58. 7.10.3 Lukang Group Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  59. 7.10.4 Lukang Group Prilide Antihypertensive Drugs Product Portfolio
  60. 7.10.5 Lukang Group Recent Developments
  61. 7.11 Likang Pharmaceutical
  62. 7.11.1 Likang Pharmaceutical Company Information
  63. 7.11.2 Likang Pharmaceutical Business Overview
  64. 7.11.3 Likang Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  65. 7.11.4 Likang Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  66. 7.11.5 Likang Pharmaceutical Recent Developments
  67. 7.12 Pfizer
  68. 7.12.1 Pfizer Company Information
  69. 7.12.2 Pfizer Business Overview
  70. 7.12.3 Pfizer Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  71. 7.12.4 Pfizer Prilide Antihypertensive Drugs Product Portfolio
  72. 7.12.5 Pfizer Recent Developments
  73. 7.13 Hengwei Pharmaceutical
  74. 7.13.1 Hengwei Pharmaceutical Company Information
  75. 7.13.2 Hengwei Pharmaceutical Business Overview
  76. 7.13.3 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  77. 7.13.4 Hengwei Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  78. 7.13.5 Hengwei Pharmaceutical Recent Developments
  79. 7.14 Hengcheng Pharmaceutical
  80. 7.14.1 Hengcheng Pharmaceutical Company Information
  81. 7.14.2 Hengcheng Pharmaceutical Business Overview
  82. 7.14.3 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  83. 7.14.4 Hengcheng Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  84. 7.14.5 Hengcheng Pharmaceutical Recent Developments
  85. 7.15 Changzhou Pharmaceutical
  86. 7.15.1 Changzhou Pharmaceutical Company Information
  87. 7.15.2 Changzhou Pharmaceutical Business Overview
  88. 7.15.3 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  89. 7.15.4 Changzhou Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  90. 7.15.5 Changzhou Pharmaceutical Recent Developments
  91. 7.16 Baili Pharmaceutical
  92. 7.16.1 Baili Pharmaceutical Company Information
  93. 7.16.2 Baili Pharmaceutical Business Overview
  94. 7.16.3 Baili Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  95. 7.16.4 Baili Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  96. 7.16.5 Baili Pharmaceutical Recent Developments
  97. 7.17 Baiyunshan Pharmaceutical
  98. 7.17.1 Baiyunshan Pharmaceutical Company Information
  99. 7.17.2 Baiyunshan Pharmaceutical Business Overview
  100. 7.17.3 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Sales, Revenue, Price and Gross Margin (2021-2026)
  101. 7.17.4 Baiyunshan Pharmaceutical Prilide Antihypertensive Drugs Product Portfolio
  102. 7.17.5 Baiyunshan Pharmaceutical Recent Developments
8 North America
  1. 8.1 North America Prilide Antihypertensive Drugs Market Size by Type
  2. 8.1.1 North America Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  3. 8.1.2 North America Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  4. 8.1.3 North America Prilide Antihypertensive Drugs Price by Type (2021-2032)
  5. 8.2 North America Prilide Antihypertensive Drugs Market Size by Application
  6. 8.2.1 North America Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  7. 8.2.2 North America Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  8. 8.2.3 North America Prilide Antihypertensive Drugs Price by Application (2021-2032)
  9. 8.3 North America Prilide Antihypertensive Drugs Market Size by Country
  10. 8.3.1 North America Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 8.3.2 North America Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 8.3.3 North America Prilide Antihypertensive Drugs Price by Country (2021-2032)
  13. 8.3.4 United States
  14. 8.3.5 Canada
  15. 8.3.6 Mexico
9 Europe
  1. 9.1 Europe Prilide Antihypertensive Drugs Market Size by Type
  2. 9.1.1 Europe Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  3. 9.1.2 Europe Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  4. 9.1.3 Europe Prilide Antihypertensive Drugs Price by Type (2021-2032)
  5. 9.2 Europe Prilide Antihypertensive Drugs Market Size by Application
  6. 9.2.1 Europe Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  7. 9.2.2 Europe Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  8. 9.2.3 Europe Prilide Antihypertensive Drugs Price by Application (2021-2032)
  9. 9.3 Europe Prilide Antihypertensive Drugs Market Size by Country
  10. 9.3.1 Europe Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 9.3.2 Europe Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 9.3.3 Europe Prilide Antihypertensive Drugs Price by Country (2021-2032)
  13. 9.3.4 Germany
  14. 9.3.5 France
  15. 9.3.6 U.K.
  16. 9.3.7 Italy
  17. 9.3.8 Russia
  18. 9.3.9 Spain
  19. 9.3.10 Netherlands
10 China
  1. 10.1 China Prilide Antihypertensive Drugs Market Size by Type
  2. 10.1.1 China Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  3. 10.1.2 China Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  4. 10.1.3 China Prilide Antihypertensive Drugs Price by Type (2021-2032)
  5. 10.2 China Prilide Antihypertensive Drugs Market Size by Application
  6. 10.2.1 China Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  7. 10.2.2 China Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  8. 10.2.3 China Prilide Antihypertensive Drugs Price by Application (2021-2032)
11 Asia (Excluding China)
  1. 11.1 Asia Prilide Antihypertensive Drugs Market Size by Type
  2. 11.1.1 Asia Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  3. 11.1.2 Asia Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  4. 11.1.3 Asia Prilide Antihypertensive Drugs Price by Type (2021-2032)
  5. 11.2 Asia Prilide Antihypertensive Drugs Market Size by Application
  6. 11.2.1 Asia Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  7. 11.2.2 Asia Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  8. 11.2.3 Asia Prilide Antihypertensive Drugs Price by Application (2021-2032)
  9. 11.3 Asia Prilide Antihypertensive Drugs Market Size by Country
  10. 11.3.1 Asia Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 11.3.2 Asia Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 11.3.3 Asia Prilide Antihypertensive Drugs Price by Country (2021-2032)
  13. 11.3.4 Japan
  14. 11.3.5 South Korea
  15. 11.3.6 India
  16. 11.3.7 Australia
  17. 11.3.8 Taiwan
  18. 11.3.9 Southeast Asia
12 South America, Middle East and Africa
  1. 12.1 SAMEA Prilide Antihypertensive Drugs Market Size by Type
  2. 12.1.1 SAMEA Prilide Antihypertensive Drugs Revenue by Type (2021-2032)
  3. 12.1.2 SAMEA Prilide Antihypertensive Drugs Sales by Type (2021-2032)
  4. 12.1.3 SAMEA Prilide Antihypertensive Drugs Price by Type (2021-2032)
  5. 12.2 SAMEA Prilide Antihypertensive Drugs Market Size by Application
  6. 12.2.1 SAMEA Prilide Antihypertensive Drugs Revenue by Application (2021-2032)
  7. 12.2.2 SAMEA Prilide Antihypertensive Drugs Sales by Application (2021-2032)
  8. 12.2.3 SAMEA Prilide Antihypertensive Drugs Price by Application (2021-2032)
  9. 12.3 SAMEA Prilide Antihypertensive Drugs Market Size by Country
  10. 12.3.1 SAMEA Prilide Antihypertensive Drugs Revenue Grow Rate by Country (2021 VS 2025 VS 2032)
  11. 12.3.2 SAMEA Prilide Antihypertensive Drugs Sales by Country (2021 VS 2025 VS 2032)
  12. 12.3.3 SAMEA Prilide Antihypertensive Drugs Price by Country (2021-2032)
  13. 12.3.4 Brazil
  14. 12.3.5 Argentina
  15. 12.3.6 Chile
  16. 12.3.7 Colombia
  17. 12.3.8 Peru
  18. 12.3.9 Saudi Arabia
  19. 12.3.10 Israel
  20. 12.3.11 UAE
  21. 12.3.12 Turkey
  22. 12.3.13 Iran
  23. 12.3.14 Egypt
13 Value Chain and Sales Channels Analysis
  1. 13.1 Prilide Antihypertensive Drugs Value Chain Analysis
  2. 13.1.1 Prilide Antihypertensive Drugs Key Raw Materials
  3. 13.1.2 Raw Materials Key Suppliers
  4. 13.1.3 Manufacturing Cost Structure
  5. 13.1.4 Prilide Antihypertensive Drugs Production Mode & Process
  6. 13.2 Prilide Antihypertensive Drugs Sales Channels Analysis
  7. 13.2.1 Direct Comparison with Distribution Share
  8. 13.2.2 Prilide Antihypertensive Drugs Distributors
  9. 13.2.3 Prilide Antihypertensive Drugs Customers
14 Concluding Insights
    15 Appendix
    1. 15.1 Reasons for Doing This Study
    2. 15.2 Research Methodology
    3. 15.3 Research Process
    4. 15.4 Authors List of This Report
    5. 15.5 Data Source
    6. 15.5.1 Secondary Sources
    7. 15.5.2 Primary Sources
    8. 15.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $4,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research, Inc.
    Talk to an analyst